Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on listing of Opus Prodox AB (publ)
Mandate

Vinge advises on listing of Opus Prodox AB (publ)

March 27, 2012

Opus is a company which develops, produces and sells products relating to automotive test equipment, vehicle inspection systems and fleet management for the global market.

Opus has retained Vinge as its legal adviser in relation to the listing. The listing process has commenced in order for the company to be included on the main list of NASDAQ OMX Stockholm in 2012.

Vinge’s team includes responsible partner Anders Strid, Anna Björk Larsson (capital markets), Ulf Käll and Anna Hofling (due diligence and tax) and Emma Kero Ljungberg (project manager for legal due diligence).

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026